Global Premature Ejaculation Therapeutics Market Insights Report 2024-2029 Featuring Prominent Vendors – Plethora Solutions, Pfizer, Eli Lilly and Co, GSK, Menarini – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Premature Ejaculation Therapeutics Market – Focused Insights 2024-2029” report has been added to... Read more.
Tellurian Board of Directors names Daniel Belhumeur as President, Meredith Mouer as General Counsel and Chief Compliance Officer
HOUSTON–(BUSINESS WIRE)–$TELL #LNG–Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) announced today that following the appointment... Read more.
Electra Therapeutics Appoints Kathy Dong, PharmD, MBA, as President and Chief Executive Officer
Company expands board of directors and appoints Matthew Fust as independent director Building on positive clinical results for its lead antibody candidate, Electra... Read more.
Kontrol Technologies Adds Carbon Sequestration Monitoring Customer
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), adds a carbon... Read more.
Gardiner Healthcare Acquisitions Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
SHAKER HEIGHTS, Ohio–(BUSINESS WIRE)–Gardiner Healthcare Acquisitions Corp. (the “Company”) (Nasdaq: GDNR, GDNRU, GDNRW), a special purpose acquisition... Read more.
Find Hokkaido Agents Welcomes Foreign Real Estate Buyers to the Neighborhood
SAPPORO, Japan–(BUSINESS WIRE)–Real estate referral company Find Hokkaido Agents has helped over 100 international visitors rent or buy real estate in... Read more.
AVPro Global, Inc. Appoints Douglas Laue as Chief Financial Officer
Seasoned Executive Brings Adept Financial Management and M&A Expertise to AVPG Team SIOUX FALLS, S.D.–(BUSINESS WIRE)–AVPro Global, Inc., parent... Read more.
Kontoor Brands Announces $300 Million Share Repurchase Program
GREENSBORO, N.C.–(BUSINESS WIRE)–$KTB–Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the... Read more.
Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs
RAHWAY, N.J.–(BUSINESS WIRE)–Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co.,... Read more.
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen... Read more.